Article Text
Commentary
NSAID-induced intestinal damage: are luminal bacteria the therapeutic target?
Statistics from Altmetric.com
Footnotes
CS is member of advisory boards for Pfizer, Boehringer-Ingelheim and Alfa Wasserman and belongs to the Speakers’ Bureau of Astra-Zeneca, Merck Sharp & Dohme and Negma-Gild.